FDA Approves BLA for Novavax’s COVID-19 Vaccine
FDA Approves Celltrion’s OMLYCLO® (omalizumab-igec)
BioNTech Acquires Biotheus To Boost Oncology Strategy
Intas Expands Cancer Therapy Biosimilar Portfolio
EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab)
STADA and Alvotech Announce Launch of UZPROVO® in Europe
Update on John Hopkins and Merck Pembrolizumab Litigation
Subscribe: Subscribe via RSS
Blogs
Firm/Org